Search by Drug Name or NDC
NDC 62135-0585-90 GLYBURIDE 5 mg/1 Details
GLYBURIDE 5 mg/1
GLYBURIDE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC. The primary component is GLYBURIDE.
MedlinePlus Drug Summary
Glyburide is used along with diet and exercise, and sometimes with other medications, to treat type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in the blood). Glyburide is in a class of medications called sulfonylureas. Glyburide lowers blood sugar by causing the pancreas to produce insulin (a natural substance that is needed to break down sugar in the body) and helping the body use insulin efficiently. This medication will only help lower blood sugar in people whose bodies produce insulin naturally. Glyburide is not used to treat type 1 diabetes (condition in which the body does not produce insulin and, therefore, cannot control the amount of sugar in the blood) or diabetic ketoacidosis (a serious condition that may occur if high blood sugar is not treated). Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Taking medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.
Related Packages: 62135-0585-90Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Glyburide
Product Information
NDC | 62135-0585 |
---|---|
Product ID | 62135-585_fbd5de64-0e52-4cc2-e053-6294a90a4cee |
Associated GPIs | |
GCN Sequence Number | 001775 |
GCN Sequence Number Description | glyburide TABLET 5 MG ORAL |
HIC3 | C4K |
HIC3 Description | ANTIHYPERGLYCEMIC, INSULIN-RELEASE STIMULANT TYPE |
GCN | 05712 |
HICL Sequence Number | 000802 |
HICL Sequence Number Description | GLYBURIDE |
Brand/Generic | Generic |
Proprietary Name | GLYBURIDE |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | GLYBURIDE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 5 |
Active Ingredient Units | mg/1 |
Substance Name | GLYBURIDE |
Labeler Name | Chartwell RX, LLC |
Pharmaceutical Class | Sulfonylurea Compounds [CS], Sulfonylurea [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA090937 |
Listing Certified Through | 2024-12-31 |
Package
NDC 62135-0585-90 (62135058590)
NDC Package Code | 62135-585-90 |
---|---|
Billing NDC | 62135058590 |
Package | 90 TABLET in 1 BOTTLE (62135-585-90) |
Marketing Start Date | 2023-05-09 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.0697 |
Pricing Unit | EA |
Effective Date | 2024-02-21 |
NDC Description | GLYBURIDE 5 MG TABLET |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 1 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |